(Q28293288)

13 July 2024

1 reference

Tristan Lindfelt

1

0 references

John O'Brien

2

0 references

Rajul Patel

4

0 references

Jessica C. Song

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20841522

13 July 2024

Dean L. Winslow

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20841522

13 July 2024

language of work or name

English

0 references

publication date

October 2010

0 references

14 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20841522

full work available at URL

13 July 2024

http://www.theannals.com/cgi/content/abstract/44/10/1572

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20841522

http://journals.sagepub.com/doi/pdf/10.1345/aph.1P141

13 July 2024

1 reference

Annals of Pharmacotherapy

13 July 2024

published in

0 references

volume

44

0 references

issue

10

0 references

page(s)

1572-8

0 references

cites work

Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro.

1 reference

The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity

21 January 2018

1 reference

Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

21 January 2018

1 reference

Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles

21 January 2018

1 reference

High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe

21 January 2018

1 reference

Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea

21 January 2018

1 reference

Genetic variability of CYP2B6 polymorphisms in four southern Chinese populations.

21 January 2018

1 reference

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

21 January 2018

1 reference

Estimation of HIV incidence in the United States

21 January 2018

1 reference

Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression

21 January 2018

1 reference

PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing

21 January 2018

1 reference

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

21 January 2018

1 reference

Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.

21 January 2018

1 reference

Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.

21 January 2018

1 reference

Drug Metabolism and Disposition

21 January 2018

2

27

1319

Mutlib AE

1999

1 reference

Metabolism of efavirenz and 8-hydroxyefavirenz by P450 2B6 leads to inactivation by two distinct mechanisms

13 July 2024

5

1 reference

13 July 2024

Identifiers

DOI

10.1345/APH.1P141

0 references